Different studies performed with elderly women in Italy, in Germany, in Sweden, in the United States, in China and in Taiwan registered expressive and variable MS occurrence 59.8%; 24% to 46%; 33% to 58%; 39%; 39.2% to 54.1%; and 54.4%, using the criteria of National Cholesterol Education Program's Adult Treatment Panel III/NECP- ATP III; NECP - ATP III and International Diabetes Federation IDF; NECP-ATP III and IDF; NECP-ATP III; NECP-ATP III and IDF; America Heart Association/National Heart Lung Blood Institute Definition/AHA\NHLBI, respectively.
Diferentes estudios conducidos con mujeres adultas mayores en Italia, Alemania, Suecia, Estados Unidos, China y Taiwan registraron ocurrencia expresiva y variable de SM 59,8%; 24% a 46%; 33% a 58%; 39%; 39,2% a 54,1%; y 54,4%, utilizando los criterios National Cholesterol Education Program's Adult Treatment Panel III/NECP- ATP III; NECP - ATP III e International Diabetes Federation IDF; NECP-ATP III e IDF; NECP-ATP III; NECP-ATP III e IDF; America Heart Association/National Heart Lung Blood Institute Definition/AHA\NHLBI, respectivamente.
Diferentes estudos conduzidos com idosas na Itália, na Alemanha, na Suécia, nos Estados Unidos, na China e em Taiwan registraram ocorrência expressiva e variável de SM 59,8%; 24% a 46%; 33% a 58%; 39%; 39,2% a 54,1%; e 54,4%, utilizando os critérios National Cholesterol Education Program's Adult Treatment Panel III/NECP- ATP III; NECP - ATP III e International Diabetes Federation IDF; NECP-ATP III e IDF; NECP-ATP III; NECP-ATP III e IDF; America Heart Association/National Heart Lung Blood Institute Definition/AHA\NHLBI, respectivamente.